Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学AML Menin Inhibitor Research

Farhad Ravandi

MD

🏢MD Anderson Cancer Center🌐USA

Professor, Department of Leukemia

78
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Farhad Ravandi is a senior leukemia expert with extensive experience in AML clinical trials and novel therapeutic strategies. His work spans FLT3 inhibitors, menin inhibitors, and measurable residual disease assessment, contributing to precision medicine approaches in AML. He has been instrumental in defining sequencing strategies for targeted agents in relapsed/refractory AML.

Share:

🧪Research Fields 研究领域

Acute promyelocytic leukemia
FLT3 inhibitors AML
Menin inhibitor sequencing
MRD assessment
Leukemia clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Farhad Ravandi 的研究动态

Follow Farhad Ravandi's research updates

留下邮箱,当我们发布与 Farhad Ravandi(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment